Gary Branning

Assistant Professor of Professional Practice

Curriculum Vitae

Mr. Branning is President of Managed Market Resources (MMR), a healthcare consulting and medical communications company, offering the pharmaceutical and biotechnology industry innovative solutions for the complex healthcare market, responsible for strategic consulting, new product development, business development, and executing Managed Market Resources strategic plan.

Previously, Mr. Branning was Executive Director of Managed Marks Marketing for Pharmacia Corporation.

Before working with Pharmacia, he worked with Quintiles Informatics as senior vice president of the Pharmaceutical Strategic Business Unit. Most of his experiences come from 17 years’ working in several areas within Parke-David: managed care, marketing, sales, business development, and finance.

Mr. Branning is recognized throughout the pharmaceutical industry for his innovative approaches to creating leading-edge programs and services with a primary focus on customer impact and corporate profitability. Mr. Branning is an adjunct professor at Rutgers Graduate School of Business and Guest Lecturer at Blench and Irwin Learner Center for Pharmaceutical Management Studies.

Mr. Branning received his Bachelor of Science degree in business administration from Wagner College, and an MBA in finance from Fairleigh Dickinson University.

Executive MBA Experience

Healthcare (HC) complexity and what all Executive Leaders need to be aware of

This 3.5-hour overview by Pharma/Healthcare veteran executive, Prof. Gary Branning, highlights some of the major challenges, pitfalls and complexities of what you as a future/current CEO need to understand fully as you navigate your company in the years ahead. Clearly, Healthcare will come to demand even greater attention at the Executive level---both from an HR as well as a Strategic Finance perspective. And with the Biden emphasis on massive HC funding, your leadership role in this area will be critical. In addition, this module is an introduction to a full, highly regarded, 3-credit Healthcare Overview and Strategy course offered by Prof. Branning in this area, as a possible elective choice (in RBS, outside EMBA) in your last semester.

Return to Executive MBA Home

2022 Best & Brightest MBAs: J. David Wiessler

Monday, May 02, 2022

Graduate students propose prize-winning solution to real-world issue exposed by pandemic

Thursday, March 11, 2021

Poets & Quants 2020 MBAs To Watch: Leah Ku

Monday, June 01, 2020

Pharmacist reinvents his future with Rutgers MBA

Thursday, April 02, 2020

UCLA and Rutgers are top winners in biopharmaceutical case competition

Monday, December 04, 2017

Media Mentions

NJ.com, So, we like Big Pharma now | Opinion, Gary Branning

Thursday, July 08, 2021

Poets & Quants, 2020 MBAs To Watch: Leah Ku, Rutgers Business School, Gary Branning

Saturday, May 30, 2020

NJBIZ, Bitter pills, Gary Branning

Monday, December 09, 2019

business.com, How Would Medicare for All Impact Small Business Owners?, Gary Branning

Tuesday, September 24, 2019

The Marshall Project, J&J medication could potentially keep people with schizophrenia out of prison, Gary Branning

Wednesday, February 14, 2018

Executive Education Programs

Mini-MBA: BioPharma Innovation

The Mini-MBA in BioPharma Innovation teaches life sciences experts key business management theory and methodology that will broaden their perspective. This course provides a better understanding of how biopharma companies plan for, and profit from, constant innovation.

In Class program: $4995.00

Online program: $3495.00

Next Class Date

Nov 14 - Nov 18, 2022

Learn More

Mini-MBA: Healthcare Management

The MiniMBA: Healthcare Management equips healthcare providers and administrators with a robust understanding of current and evolving regulatory and compliance requirements, compensation models, patient expectations, key business practices, legal considerations and practice management techniques. With a strong background in these critical, contextual elements of healthcare, providers can focus on their main priority--excellent clinical care.

In Class program: $3495.00